×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GANX – gain therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GANX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
07:35 am
ganx
Gain Therapeutics GAAP EPS of -$0.17 [Seeking Alpha]
Low
Report
Gain Therapeutics GAAP EPS of -$0.17 [Seeking Alpha]
11/14
04:17 pm
ganx
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update [Yahoo! Finance]
11/14
04:05 pm
ganx
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
Medium
Report
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
10/23
08:00 am
ganx
Gain Therapeutics Presents Data at 36?? EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2
Medium
Report
Gain Therapeutics Presents Data at 36?? EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2
10/15
07:00 am
ganx
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Low
Report
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10/9
08:33 am
ganx
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Gain Therapeutics, Inc. (NASDAQ: GANX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
10/9
08:30 am
ganx
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
Medium
Report
Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference
10/7
07:00 am
ganx
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024
High
Report
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:09 pm
ganx
Form 10-Q Gain Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q Gain Therapeutics, Inc. For: Sep 30
11/14
04:03 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Nov 14
Medium
Report
Form 8-K Gain Therapeutics, Inc. For: Nov 14
10/21
05:23 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Oct 21
Medium
Report
Form 8-K Gain Therapeutics, Inc. For: Oct 21
10/8
04:31 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Oct 07
Medium
Report
Form 8-K Gain Therapeutics, Inc. For: Oct 07
9/19
06:16 am
ganx
Form S-8 Gain Therapeutics, Inc.
Neutral
Report
Form S-8 Gain Therapeutics, Inc.
9/6
05:02 pm
ganx
Form 424B5 Gain Therapeutics, Inc.
High
Report
Form 424B5 Gain Therapeutics, Inc.
9/6
05:00 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Sep 06
High
Report
Form 8-K Gain Therapeutics, Inc. For: Sep 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: